%0 Journal Article
%T Cognitive function among hemodialysis patients in Japan
%A Gen Odagiri
%A Norio Sugawara
%A Atsuhiro Kikuchi
%A Ippei Takahashi
%A Takashi Umeda
%A Hisao Saitoh
%A Norio Yasui-Furukori
%A Sunao Kaneko
%J Annals of General Psychiatry
%D 2011
%I BioMed Central
%R 10.1186/1744-859x-10-20
%X Using a cross-sectional design, we administered the Mini-Mental State Examination (MMSE) to 154 HD outpatients and 852 participants from the Iwaki Health Promotion Project 2010, representing the general population.The prevalence of cognitive impairment based on the MMSE was 18.8% in HD patients. HD patients showed a higher prevalence of cognitive impairment in older groups (50 years and older). In a logistic regression model with age, gender and amount of education as covariates, undergoing HD was a significant independent factor (OR = 2.28, 95% CI 1.33 to 3.94) associated with a lower MMSE score. Among HD patients, we found that level of education was associated with MMSE score.There is a high prevalence of cognitive impairment among HD patients that has adverse implications for hospitalization and shortens their life expectancy. HD treatment was an independent risk factor for cognitive impairment. Clinicians should carefully monitor and treat cognitive impairment in HD patients. Further studies are required to determine the reasons for cognitive impairment in HD patients.Advances in medical technology and improvements in public health have brought about a progressive increase in the population undergoing hemodialysis (HD). Over 290,000 patients receive HD in Japan, which has the world's highest rate of dialysis treatment (2,280 per million people) as of December 2009 [1]. The prevalence of HD treatment sharply increases in old age, as does the prevalence of cognitive impairment.Recently, the relationship between HD and cognitive impairment has attracted attention [2-5], and its causes have been discussed. A previous study [3] of 80 HD patients (mean age, 61.2 ¡À 14.3 years) found severe levels of impairment in executive function (38%), as measured by the Trail Making Test B, Part B (Trails B), and severe memory impairment (33%) based on the short form of the California Verbal Learning Trial (CVLT). A more recent study [4] assessing cognitive function across multipl
%U http://www.annals-general-psychiatry.com/content/10/1/20